INTRODUCTION: Premature ventricular contractions (PVCs) frequently occur in patients with left ventricular dysfunction. However, there are limited data regarding the burden and morphologic characteristics of PVCs in patients receiving cardiac resynchronization therapy. METHODS AND RESULTS:Patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT) with >5000 PVCs on a predevice implant 12-lead, 24-hour Holter were identified. The putative PVC site of origin for the most dominant PVC was characterized and their effects on clinical outcomes were evaluated. A total of 146 patients were identified to have >5000 PVCs on Holter of which 75 (51%) had PVCs originating from a non-outflow tract site. Other sites included the left ventricular outflow tract (LVOT), right ventricular outflow tract (RVOT), and the sinus of Valsalva. In multivariate analysis, the risk for HF/Deatd was similar in patients with Outflow tract PVCs when compared to patients with Non-outflow tract PVCs (HR 1.4, 95% CI 0.7-2.8, P = 0.3). The degree of echocardiographic reverse remodeling was similar in patients with outflow tract versus Non-outflow tract PVCs. One-third of patients with nonischemic cardiomyopathy were found to have PVCs originating from the RVOT. CONCLUSIONS: In patients with mild symptoms of heart failure, there is no difference in the risk of HF or death in patients with outflow versus non-outflow tract PVCs. One-third of patients with NICM have frequent PVCs originating from the RVOT.
RCT Entities:
INTRODUCTION:Premature ventricular contractions (PVCs) frequently occur in patients with left ventricular dysfunction. However, there are limited data regarding the burden and morphologic characteristics of PVCs in patients receiving cardiac resynchronization therapy. METHODS AND RESULTS:Patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT) with >5000 PVCs on a predevice implant 12-lead, 24-hour Holter were identified. The putative PVC site of origin for the most dominant PVC was characterized and their effects on clinical outcomes were evaluated. A total of 146 patients were identified to have >5000 PVCs on Holter of which 75 (51%) had PVCs originating from a non-outflow tract site. Other sites included the left ventricular outflow tract (LVOT), right ventricular outflow tract (RVOT), and the sinus of Valsalva. In multivariate analysis, the risk for HF/Deatd was similar in patients with Outflow tract PVCs when compared to patients with Non-outflow tract PVCs (HR 1.4, 95% CI 0.7-2.8, P = 0.3). The degree of echocardiographic reverse remodeling was similar in patients with outflow tract versus Non-outflow tract PVCs. One-third of patients with nonischemic cardiomyopathy were found to have PVCs originating from the RVOT. CONCLUSIONS: In patients with mild symptoms of heart failure, there is no difference in the risk of HF or death in patients with outflow versus non-outflow tract PVCs. One-third of patients with NICM have frequent PVCs originating from the RVOT.
Authors: Timir S Baman; Dave C Lange; Karl J Ilg; Sanjaya K Gupta; Tzu-Yu Liu; Craig Alguire; William Armstrong; Eric Good; Aman Chugh; Krit Jongnarangsin; Frank Pelosi; Thomas Crawford; Matthew Ebinger; Hakan Oral; Fred Morady; Frank Bogun Journal: Heart Rhythm Date: 2010-03-27 Impact factor: 6.343
Authors: Suneet Mittal; Mehmet K Aktas; Arthur J Moss; Scott McNitt; Valentina Kutyifa; Jonathan S Steinberg; Wojciech Zareba Journal: J Cardiovasc Electrophysiol Date: 2014-06-24
Authors: Arthur J Moss; Mary W Brown; David S Cannom; James P Daubert; Mark Estes; Elyse Foster; Henry M Greenberg; W Jackson Hall; Steven L Higgins; Helmut Klein; Mark Pfeffer; David Wilber; Wojciech Zareba Journal: Ann Noninvasive Electrocardiol Date: 2005-10 Impact factor: 1.468
Authors: Ravi K Yarlagadda; Sei Iwai; Kenneth M Stein; Steven M Markowitz; Bindi K Shah; Jim W Cheung; Vivian Tan; Bruce B Lerman; Suneet Mittal Journal: Circulation Date: 2005-08-15 Impact factor: 29.690
Authors: Yumiko Kanei; Meir Friedman; Naomi Ogawa; Sam Hanon; Patrick Lam; Paul Schweitzer Journal: Ann Noninvasive Electrocardiol Date: 2008-01 Impact factor: 1.468
Authors: Martin H Ruwald; Suneet Mittal; Anne-Christine Ruwald; Mehmet K Aktas; James P Daubert; Scott McNitt; Amin Al-Ahmad; Christian Jons; Valentina Kutyifa; Jonathan S Steinberg; Paul Wang; Arthur J Moss; Wojciech Zareba Journal: J Am Coll Cardiol Date: 2014-09-09 Impact factor: 24.094
Authors: Worawan B Limpitikul; Thomas A Dewland; Eric Vittinghoff; Elsayed Soliman; Gregory Nah; Christina Fang; David S Siscovick; Bruce M Psaty; Nona Sotoodehnia; Susan Heckbert; Phyllis K Stein; John Gottdiener; Xiao Hu; Ralf Hempfling; Gregory M Marcus Journal: Heart Date: 2021-09-07 Impact factor: 5.994
Authors: Finn Akerström; Marta Pachón; José B Martínez-Ferrer; Javier Alzueta; Luisa Pérez; Ignacio Fernández Lozano; Anibal Rodríguez; Miguel A Arias Journal: Indian Pacing Electrophysiol J Date: 2020-03-09